This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Csaba Szabo, MD, PhD
Children's Hospital Medical Center Cincinnati, Ohio

Robert Kilbourn, MD, PhD
Rush-Presbyterian-St Luke's Medical Center Chicago, Ill

JAMA. 1996;276(10):781.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Drs Cobb and Danner¹ describe 2 case reports and provide an overview of the literature that is presented in an unbalanced perspective and is inconsistent with the available knowledge in the field. Although the review quotes many references, much of the basis for the conclusions are from 2 experiments, both originating from the authors' own laboratory. As a result, the authors tend to look at the field as a whole in the perspective of these 2 reports, which have major flaws.

First, the dose of endotoxin used to induce lethality is 400 times greater than the dose that causes moderate to severe hypotension in dogs. Indeed, the same group worked diligently for years to develop a sepsis model using an intraperitoneal septic clot that more closely simulates the human cardiovascular response than the endotoxin bolus model. Interestingly, when they finally used the clot model to study . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?